Table 1. Invasive Candidiasis Treatment Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Invasive Candidiasis Treatment Drug Market Restraints

Table 3. Invasive Candidiasis Treatment Drug Market Trends

Table 4. Invasive Candidiasis Treatment Drug Industry Policy

Table 5. Global Invasive Candidiasis Treatment Drug Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Company (2018-2023)

Table 7. Global Invasive Candidiasis Treatment Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Invasive Candidiasis Treatment Drug Mergers & Acquisitions, Expansion Plans

Table 9. Global Invasive Candidiasis Treatment Drug Manufacturers Product Type

Table 10. China Invasive Candidiasis Treatment Drug Revenue by Company (2018-2023) & (US$ million)

Table 11. China Invasive Candidiasis Treatment Drug Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Invasive Candidiasis Treatment Drug Upstream (Raw Materials)

Table 13. Global Invasive Candidiasis Treatment Drug Typical Customers

Table 14. Invasive Candidiasis Treatment Drug Typical Distributors

Table 15. By Type, Global Invasive Candidiasis Treatment Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Invasive Candidiasis Treatment Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Invasive Candidiasis Treatment Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Invasive Candidiasis Treatment Drug Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Invasive Candidiasis Treatment Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Invasive Candidiasis Treatment Drug Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Invasive Candidiasis Treatment Drug Revenue Market Share, 2018-2029

Table 22. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

Table 23. GlaxoSmithKline Company Profile and Main Business

Table 24. GlaxoSmithKline Invasive Candidiasis Treatment Drug Models, Specifications and Application

Table 25. GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue and Gross Margin, 2018-2023

Table 26. GlaxoSmithKline Recent Developments

Table 27. Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position

Table 28. Merck & Co., Inc Company Profile and Main Business

Table 29. Merck & Co., Inc Invasive Candidiasis Treatment Drug Models, Specifications and Application

Table 30. Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue and Gross Margin, 2018-2023

Table 31. Merck & Co., Inc Recent Developments

Table 32. Pfizer Inc Company Information, Head Office, Market Area and Industry Position

Table 33. Pfizer Inc Company Profile and Main Business

Table 34. Pfizer Inc Invasive Candidiasis Treatment Drug Models, Specifications and Application

Table 35. Pfizer Inc Invasive Candidiasis Treatment Drug Revenue and Gross Margin, 2018-2023

Table 36. Pfizer Inc Recent Developments

Table 37. Cidara Therapeutics, Inc Company Information, Head Office, Market Area and Industry Position

Table 38. Cidara Therapeutics, Inc Company Profile and Main Business

Table 39. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Models, Specifications and Application

Table 40. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue and Gross Margin, 2018-2023

Table 41. Cidara Therapeutics, Inc Recent Developments

Table 42. Astellas Pharma Inc Company Information, Head Office, Market Area and Industry Position

Table 43. Astellas Pharma Inc Company Profile and Main Business

Table 44. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Models, Specifications and Application

Table 45. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue and Gross Margin, 2018-2023

Table 46. Astellas Pharma Inc Recent Developments

Table 47. Gilead Sciences, Inc Company Information, Head Office, Market Area and Industry Position

Table 48. Gilead Sciences, Inc Company Profile and Main Business

Table 49. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Models, Specifications and Application

Table 50. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue and Gross Margin, 2018-2023

Table 51. Gilead Sciences, Inc Recent Developments

Table 52. Novo Nordisk A/S (Xellia Pharmaceuticals) Company Information, Head Office, Market Area and Industry Position

Table 53. Novo Nordisk A/S (Xellia Pharmaceuticals) Company Profile and Main Business

Table 54. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Models, Specifications and Application

Table 55. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue and Gross Margin, 2018-2023

Table 56. Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments

Table 57. Biosergen AB Company Information, Head Office, Market Area and Industry Position

Table 58. Biosergen AB Company Profile and Main Business

Table 59. Biosergen AB Invasive Candidiasis Treatment Drug Models, Specifications and Application

Table 60. Biosergen AB Invasive Candidiasis Treatment Drug Revenue and Gross Margin, 2018-2023

Table 61. Biosergen AB Recent Developments

Table 62. Matinas BioPharma Holdings, Inc Company Information, Head Office, Market Area and Industry Position

Table 63. Matinas BioPharma Holdings, Inc Company Profile and Main Business

Table 64. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Models, Specifications and Application

Table 65. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue and Gross Margin, 2018-2023

Table 66. Matinas BioPharma Holdings, Inc Recent Developments

Table 67. Pulmocide Ltd Company Information, Head Office, Market Area and Industry Position

Table 68. Pulmocide Ltd Company Profile and Main Business

Table 69. Pulmocide Ltd Invasive Candidiasis Treatment Drug Models, Specifications and Application

Table 70. Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue and Gross Margin, 2018-2023

Table 71. Pulmocide Ltd Recent Developments

Table 72. F2G Ltd Company Information, Head Office, Market Area and Industry Position

Table 73. F2G Ltd Company Profile and Main Business

Table 74. F2G Ltd Invasive Candidiasis Treatment Drug Models, Specifications and Application

Table 75. F2G Ltd Invasive Candidiasis Treatment Drug Revenue and Gross Margin, 2018-2023

Table 76. F2G Ltd Recent Developments

List of Figure

Figure 1. Invasive Candidiasis Treatment Drug Picture

Figure 2. Global Invasive Candidiasis Treatment Drug Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Invasive Candidiasis Treatment Drug Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Invasive Candidiasis Treatment Drug Market Share of Global

Figure 5. Global Invasive Candidiasis Treatment Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Invasive Candidiasis Treatment Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Invasive Candidiasis Treatment Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Invasive Candidiasis Treatment Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Invasive Candidiasis Treatment Drug Industry Chain

Figure 10. Azoles Drug

Figure 11. Echinocandins Drug

Figure 12. Allylamines Drug

Figure 13. Polyenes Drug

Figure 14. Others

Figure 15. By Type, Global Invasive Candidiasis Treatment Drug Revenue, 2018-2029, US$ Million

Figure 16. By Type, Global Invasive Candidiasis Treatment Drug Revenue Market Share, 2018-2029

Figure 17. Hospital

Figure 18. Clinic

Figure 19. Others

Figure 20. By Application, Global Invasive Candidiasis Treatment Drug Revenue, 2018-2029, US$ Million

Figure 21. By Application, Global Invasive Candidiasis Treatment Drug Revenue Market Share, 2018-2029

Figure 22. By Region, Global Invasive Candidiasis Treatment Drug Revenue Market Share, 2018-2029

Figure 23. North America Invasive Candidiasis Treatment Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, North America Invasive Candidiasis Treatment Drug Revenue Market Share, 2018-2023

Figure 25. Europe Invasive Candidiasis Treatment Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country, Europe Invasive Candidiasis Treatment Drug Revenue Market Share, 2018-2023

Figure 27. Asia Pacific Invasive Candidiasis Treatment Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country/Region, Asia Pacific Invasive Candidiasis Treatment Drug Revenue Market Share, 2018-2023

Figure 29. South America Invasive Candidiasis Treatment Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. By Country, South America Invasive Candidiasis Treatment Drug Revenue Market Share, 2018-2023

Figure 31. Middle East & Africa Invasive Candidiasis Treatment Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 32. U.S. Invasive Candidiasis Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 33. By Company, U.S. Invasive Candidiasis Treatment Drug Market Share, 2018-2023

Figure 34. By Type, U.S. Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 35. By Application, U.S. Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 36. Europe Invasive Candidiasis Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 37. By Company, Europe Invasive Candidiasis Treatment Drug Market Share, 2018-2023

Figure 38. By Type, Europe Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 39. By Application, Europe Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 40. China Invasive Candidiasis Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 41. By Company, China Invasive Candidiasis Treatment Drug Market Share, 2018-2023

Figure 42. By Type, China Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 43. By Application, China Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 44. Japan Invasive Candidiasis Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 45. By Company, Japan Invasive Candidiasis Treatment Drug Market Share, 2018-2023

Figure 46. By Type, Japan Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 47. By Application, Japan Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 48. South Korea Invasive Candidiasis Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 49. By Company, South Korea Invasive Candidiasis Treatment Drug Market Share, 2018-2023

Figure 50. By Type, South Korea Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 51. By Application, South Korea Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 52. Southeast Asia Invasive Candidiasis Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 53. By Company, Southeast Asia Invasive Candidiasis Treatment Drug Market Share, 2018-2023

Figure 54. By Type, Southeast Asia Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 55. By Application, Southeast Asia Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 56. India Invasive Candidiasis Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 57. By Company, India Invasive Candidiasis Treatment Drug Market Share, 2018-2023

Figure 58. By Type, India Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 59. By Application, India Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 60. Middle East & Asia Invasive Candidiasis Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 61. By Company, Middle East & Asia Invasive Candidiasis Treatment Drug Market Share, 2018-2023

Figure 62. By Type, Middle East & Asia Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 63. By Application, Middle East & Asia Invasive Candidiasis Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 64. Research Methodology

Figure 65. Breakdown of Primary Interviews

Figure 66. Bottom-up Approaches

Figure 67. Top-down Approaches